Philogen's Philochem AG research unit will provide Merck's Merck Serono S.A. mAbs against undisclosed targets for Merck Serono to use in identifying molecular biomarkers of oocyte and embryo quality

Philogen S.p.A.

Italy / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Merck Serono S.A.

Switzerland / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced